neoDL: a novel neoantigen intrinsic feature-based deep learning model identifies IDH wild-type glioblastomas with the longest survival
Background: Neoantigen based personalized immune therapies achieve promising results in melanoma and lung cancer, but few neoantigen based models perform well in IDH wild-type GBM, and the association between neoantigen intrinsic features and prognosis remain unclear in IDH wild-type GBM. We present...
Main Authors: | Chen, Y. (Author), Fan, Y. (Author), Han, X. (Author), He, Y. (Author), Li, J. (Author), Li, L. (Author), Li, W. (Author), Liu, G. (Author), Liu, Y. (Author), Sun, T. (Author), Wang, H. (Author), Wang, L. (Author), Wen, H. (Author), Xiao, Z. (Author), Zhang, J. (Author), Zhang, W. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central Ltd
2021
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
neoDL: a novel neoantigen intrinsic feature-based deep learning model identifies IDH wild-type glioblastomas with the longest survival
by: Ting Sun, et al.
Published: (2021-07-01) -
<i>IDH</i> Mutations in Glioma: Double-Edged Sword in Clinical Applications?
by: Alisan Kayabolen, et al.
Published: (2021-07-01) -
Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery
by: Patrick J. Cimino, et al.
Published: (2017-05-01) -
A Phase Ib Clinical Trial of Metformin and Chloroquine in Patients with <i>IDH1</i>-Mutated Solid Tumors
by: Mohammed Khurshed, et al.
Published: (2021-05-01) -
Diagnostic performance of clinical properties and conventional magnetic resonance imaging for determining the IDH1 mutation status in glioblastoma: a retrospective study
by: Qun Wang, et al.
Published: (2019-06-01)